As of 2025-03-19, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (38.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -53602.2%.
The range of the Relative Valuation is (39.06) - (39.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 24.7x | 22.4x |
| Forward P/E multiples | 18.7x - 21.3x | 18.9x |
| Fair Price | (39.06) - (39.92) | (38.63) |
| Upside | -54198.1% - -55389.9% | -53602.2% |
| Date | P/E |